PTC Therapeutics signs lease with Bristol-Myers Squibb — 3 insights

Eric Oliver -   Print  |
Listen

PTC Therapeutics is leasing a 185,000-square-foot biologics-focused research space from Bristol-Myers Squibb, BioPharmaReport.com reports.

What you should know:

1. PTC entered into a 15-year lease. The space includes a biologics production facility, research spaces and operations buildings.

2. PTC will develop the biologics facility to support its gene therapy production capabilities. The site is pivoting its current production schedule to create materials to support PTC's preclinical and clinical programs.

3. PTC also intends to relocate its research operations to the site.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers